Literature DB >> 24693544

Reply to Domenech de Cellès et al.: Infection and transmission of pertussis in the baboon model.

Jason M Warfel, Tod J Merkel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24693544      PMCID： PMC3932914          DOI： 10.1073/pnas.1324074111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Airborne transmission of Bordetella pertussis.

Authors:  Jason M Warfel; Joel Beren; Tod J Merkel
Journal:  J Infect Dis       Date:  2012-07-17       Impact factor: 5.226

2.  Pertussis epidemic--Washington, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-07-20       Impact factor: 17.586

3.  Epidemiological evidence for herd immunity induced by acellular pertussis vaccines.

Authors:  Matthieu Domenech de Cellès; Maria A Riolo; Felicia M G Magpantay; Pejman Rohani; Aaron A King
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

4.  Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.

Authors:  Lennart Nilsson; Tiia Lepp; Kerstin von Segebaden; Hans Hallander; Lennart Gustafsson
Journal:  Vaccine       Date:  2011-11-15       Impact factor: 3.641

5.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205
  5 in total
  3 in total

1.  Vaccine-driven virulence evolution: consequences of unbalanced reductions in mortality and transmission and implications for pertussis vaccines.

Authors:  Ian F Miller; C Jessica Metcalf
Journal:  J R Soc Interface       Date:  2019-12-11       Impact factor: 4.118

2.  Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis.

Authors:  Bo-Hyun Cho; Anna M Acosta; Andrew J Leidner; Amanda E Faulkner; Fangjun Zhou
Journal:  Prev Med       Date:  2020-03-19       Impact factor: 4.018

3.  Asymptomatic transmission and the resurgence of Bordetella pertussis.

Authors:  Benjamin M Althouse; Samuel V Scarpino
Journal:  BMC Med       Date:  2015-06-24       Impact factor: 8.775
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.